gynecological tumor
Conditions
Interventions
Obtaining consent and then performing FES PET and FDGPET tests. One month before the start of treatment, measuring SUV values in tumors and Comparing with clinical data. The method of administration
after fasting from 5 hours ago, FES with a radiation isotope of 6 mCi, injected intravenously. After one hour, using a PET device capable of full body scanning of radiation, to image the accumulation
Sponsors
Department of Obstetrics and Gynecology, Fukui University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The patients are patients with treatable uterine fibroids, uterine sarcoma, endometrial cancer, and endometrial hyperplasia.
Exclusion criteria
Exclusion criteria: When the subject requests to decline to participate in the test or withdraws her consent If the pregnancy is found If the entire exam is canceled If, for other reasons, the doctor determines that it is appropriate to stop the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It becomes possible to distinguish between uterine fibroids and sarcomas | — |
Secondary
| Measure | Time frame |
|---|---|
| It becomes possible to determine the indication and effect of fertility preservation treatment for early endometrial cancer and precancerous lesions | — |
Countries
Japan
Contacts
Public ContactHideaki Tsuyoshi
Fukui University Department of Obstetrics and Gynecology
Outcome results
None listed